U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ISATUXIMAB
R30772KCU0
US Approved Rx (2020)
First approved in 2020
General
Record Details
Variant Concepts
1
Names
9
Classification
2
Identifiers
16
Subunits
4
Disulfide Links
16
Glycosylation
2
Relationships
2
Active Moiety
1
Characteristic Attributes
2
ISATUXIMAB
R30772KCU0
US Approved Rx (2020)
First approved in 2020
General
Approval Year
2020
742
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG1
Sequence Origin
MOUSE CHIMERIC
Sequence Type
COMPLETE
Record UNII
R30772KCU0
Record Status
Validated (UNII)
Record Version
30
29
28
27
26
25
24
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Show
5
20
100
All
entries
Related Record
Type
Related Record
Type
No data available in table
Showing 0 to 0 of 0 entries
Previous
Next
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
ISATUXIMAB
Official Name
English
ISATUXIMAB [USAN]
Common Name
English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD38 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HU38SB19 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HU38SB19 LIGHT CHAIN, DIMER
Systematic Name
English
SAR-650984
Code
English
isatuximab [INN]
Common Name
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of multiple myeloma
FDA ORPHAN DRUG
431914
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
16
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
RXCUI
2282018
PRIMARY
ChEMBL
CHEMBL3545131
PRIMARY
DRUG BANK
DB14811
PRIMARY
DAILYMED
R30772KCU0
PRIMARY
ChEMBL
CHEMBL2109270
PRIMARY
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Subunits
4
Disulfide Links
16
Show
5
20
100
All
entries
From
To
From
To
1_22
1_96
1_147
1_203
1_264
1_324
1_370
1_428
2_22
2_96
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Glycosylation
2
Glycosylation Type
MAMMALIAN
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_300
N
2_300
Showing 1 to 2 of 2 entries
Previous
1
Next
Relationships
2
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
JMN849I3XV
ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1
TARGET->LIGAND
ISATUXIMAB-IRFC
SUB_CONCEPT->SUBSTANCE
Amount:
Showing 1 to 2 of 2 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
R30772KCU0
ISATUXIMAB
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
C6456H9926N1700O2028S44
MOL_WEIGHT:CALCULATED(G0F-G0F glycosylated form)
CHEMICAL
CALCULATED 147825 AMU (average)
Showing 1 to 2 of 2 entries
Previous
1
Next
